Hilar Cholangiocarcinoma
Hilar cholangiocarcinoma is a rare cancer that occurs in the bile ducts at the point where they enter the liver, often leading to symptoms related to bile duct obstruction.
We are studying whether radiofrequency ablation or photodynamic therapy helps patients with cholangiocarcinoma live longer. We’ll also look at how these treatments affect quality of life and any potential side effects.
Health conditions and diseases that the clinical trial is designed to study and treat.
Hilar cholangiocarcinoma is a rare cancer that occurs in the bile ducts at the point where they enter the liver, often leading to symptoms related to bile duct obstruction.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.